Transcription of Assessment report
{{id}} {{{paragraph}}}
Official address Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands An agency of the European Union Address for visits and deliveries Refer to Send us a question Go to Telephone +31 (0)88 781 6000 European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged. 25 March 2021 EMA/CHMP/206970/2021 Committee for Medicinal Products for Human Use (CHMP) Assessment report Ponvory International non-proprietary name: ponesimod Procedure No. EMEA/H/C/005163/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted. Assessment report EMA/CHMP/206970/2021 Page 2/136 Table of contents 1. Background information on the procedure .. 8 Submission of the dossier .. 8 Steps taken for the Assessment of the product.
Assessment report EMA/CHMP/206970/2021 Page 5/136 Erk1/2 Extracellular signal-Regulated Kinase 1/2 ESR Erythrocyte Sedimentation Rate ETA EU
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}